Twitter

Archive for November 23rd, 2011


Four Types Of Malignant Tumors

Cancer may be malignant or benign. By the use of the types of cells that type the tumor and by the trait options of those tumors, they are labeled as carcinomas, sarcomas, lymphomas and leukemias. A number of varieties of illustrative examinations are there to verify, which forms of illness a patient possesses. We’ll deal [...]

Read More...

Side Effects Of Radiation For Colorectal Cancer

Colorectal cancer could be cured most often, when it is identified in early stages. It is the medical oncologists, gastroenterologists, radiation oncologists and surgeons, who specialise in treating such cancers in women. Colorectal most cancers could also be treated depending upon the precise location of the tumour current, its stage and size. Though surgical procedure [...]

Read More...

Painting parties a good ol’ standby for cancer treatment recovery

This is part of a series in which Amy Graff of Hobart shares her experiences with breast-cancer diagnosis and treatment.

Read More...

Coming Clean | Can we solve the problem of carcinogens in the environment?

Last year, at age 45, I joined a growing community: I was diagnosed with melanoma.

Read More...

Columbia study finds colon cancer screening campaign in NYC erases racial, ethnic, and gender gaps in use of colonoscopy:

In 2003, New York City launched a multifaceted campaign to improve colonoscopy rates among racial and ethnic minorities and women. A new study conducted by researchers at the Mailman School and the NYC Department of Health and Mental Hygiene demonstrates the notable success of the campaign. Results show a 20-percentage point jump in colonoscopy screenings among all New Yorkers ages 50 and older and the elimination of disparities across several demographic populations.

Read More...

UC San Diego study identifies two cancer drugs that may target a form of glioblastoma:

Scientists at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center, in collaboration with colleagues in Boston and South Korea, say they have identified a novel gene mutation that causes at least one form of glioblastoma (GBM), the most common type of malignant brain tumor… Perhaps more importantly, the researchers found that two drugs already being used to treat other forms of cancer effectively prolonged the survival of mice modeling this particular form of GBM.

Read More...

University of Michigan researchers find genetic rearrangements driving 5 to 7 percent of breast cancers:

Researchers at the University of Michigan Comprehensive Cancer Center have discovered two cancer-spurring gene rearrangements that may trigger 5 to 7 percent of all breast cancers.

Read More...

Sanford-Burnham researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment:

Researchers at Sanford-Burnham Medical Research Institute are developing techniques to deliver cancer drugs directly to tumors, increasing their effectiveness and decreasing collateral damage. In a study published the week of November 21 in the Proceedings of the National Academy of Sciences of the USA, a team coupled a cancer drug to a small protein called IF7, which is specifically attracted to the blood vessels that feed tumors.

Read More...

Collaborative study finds mortality rates for pharynx and mouth cancers have decreased:

Death rates have declined among U.S. patients with cancer of the mouth and pharynx from 1993 to 2007, with the greatest decreases seen among men and women with at least 12 years of education, according to a report in the November issue of the Archives of Otolaryngology – Head & Neck Surgery, one of the JAMA/Archives journals.

Read More...

Ohio State scientists develop model for future prostate cancer treatments guided by math:

Scientists have designed a first draft of a mathematical model that someday could guide treatment decisions for advanced prostate cancer, in part by helping doctors predict how individual patients will respond to therapy based on the biology of their tumors.

Read More...